20
Teva Pharmaceutical Industries Ltd, based in Ireland, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is PRILOCAINE USP, with a corresponding US DMF Number 15772.
Remarkably, this DMF maintains an Active status since its submission on December 18, 2001, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of May 31, 2018, and payment made on April 29, 2018, indicating their dedication to facilitating drug approvals, Categorized as Type II